Hemp Industry
Eight Years After Decriminalisation, South Africa’s Cannabis Industry Edges Towards Regulated Market
South Africa, according to its own government, already has a cannabis industry worth up to R28bn (£1.28bn).
regulation
51stories
21 Aprlast updated
More in regulation
- Uncategorized
FSA Shifts Gears: Reformulation, THC Tolerance, and Faster CBD Approvals Appear to Be On the Horizon
This morning, the UK’s Food Standards Agency (FSA) announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel.
- Data & Analysis
What Comes Next for UK Medical Cannabis?
Though large-scale reform does not currently appear forthcoming, there are small-scale, more targeted measures that could feasibly be taken by UK authorities in the coming years which would be positive for the medical cannabis industry.
- Adult-Use
Thailand Publishes New Draft Bill To Regulate Cannabis Instead of Ban it Outright
In recent months, Thailand has become a biword for the negative impact of cannabis liberalisation policy without adequate planning and forethought.
- Uncategorized
Cannabis Operators File Lawsuit Seeking Equal Treatment
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine.
- Uncategorized
Federal Cannabis Legalisation Could Wipe Out State Markets, Says Report
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine.
- Uncategorized
How cannabis rescheduling could create new opportunities for banking
Last week, the U.S Department of Health and Human Services (HHS) urged the Drug Enforcement Administration (DEA) to reclassify cannabis from Schedule I to Schedule III under federal law.
- Uncategorized
HHS Recommends Reclassifying Cannabis from Schedule I to Schedule III Under Federal Law
The U.S Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be reclassified from Schedule I to Schedule III under federal law.
- CBD Market
FDA to create new regulatory pathway for CBD products
The U.S. Food and Drug Administration (FDA) has announced it will be creating a new regulatory path for CBD products as current regulations are not suitable.
